Am Fam Physician. 2024;109(1):online
Author disclosure: No relevant financial relationships.
Details for This Review
Study Population: A total of 98,816 mother-infant pairs across 103 studies, which included healthy pregnant women who intended to breast-feed and recently delivered (vaginal or cesarean) healthy, term infants; of the studies, 17% involved low- and middle-income countries; exclusion criteria included chronic illnesses such as diabetes mellitus, HIV, and obesity
Efficacy End Points: Primary outcomes: cessation of any or exclusive breastfeeding at four to six weeks postpartum and at six months postpartum; secondary outcomes: cessation of any or exclusive breastfeeding at two months, three to four months, nine months, and 12 months postpartum; maternal satisfaction with care and feeding method; all-cause neonatal and infant mortality; and maternal mental health
Harm End Points: No specific harms were identified or reported
| Benefits of breastfeeding support alone |
| Any breastfeeding |
| 1 in 28 at 4 to 6 weeks |
| 1 in 17 at 3 to 4 months |
| 1 in 24 at 6 months |
| Exclusive breastfeeding |
| 1 in 12 at 4 to 6 weeks |
| 1 in 9 at 2 months |
| 1 in 8 at 3 to 4 months |
| 1 in 12 at 6 months |
| 1 in 11 at 9 months |
| Benefits of breastfeeding support plus an additional intervention to benefit mother and infant health |
| Any breastfeeding |
| 1 in 31 at 6 months |
| Exclusive breastfeeding |
| 1 in 7 at 4 to 6 weeks |
| 1 in 7 at 6 months |
Subscribe
From $165- Immediate, unlimited access to all AFP content
- More than 130 CME credits/year
- AAFP app access
- Print delivery available
Issue Access
$59.95- Immediate, unlimited access to this issue's content
- CME credits
- AAFP app access
- Print delivery available
